Abstract
The metabolism of flavopiridol (FLAP), a novel anticancer drug currently undergoing clinical development, was investigated in rat and human liver microsomes. In the presence of uridine 5′-diphosphoglucuronic acid, two biotransformation products (M1 and M2) could be detected. Formation of metabolite M1 and M2 in terms of enzymatic efficacy (Vmax/KM) was about 50- and 5-fold higher in rat (1.58 ± 2.23 and 7.22 ± 1.17 μl/min/mg) as compared with human liver microsomes (0.032 ± 0.016 and 1.52 ± 0.93 μl/min/mg), indicating species-related differences in FLAP glucuronidation. Incubation in the presence of human recombinant UDP-glucuronosyltransferases (UGTs) demonstrated that M1 is almost exclusively catalyzed by UGT1A1, whereas M2 is formed by UGT1A9 and only to a minor extent by UGT1A1 and UGT1A10. Chemical inhibition experiments further prove the involvement of UGT1A1 and UGT1A9 in the formation of M1 and M2, as the UGT1A1 substrate bilirubin preferably inhibited M1 over M2 (Ki: 36 and 258 μM, respectively), whereas the UGT1A9 substrate propofol showed a more pronounced decrease in M2 but not in M1 formation (Ki: 47 and 142 μM, respectively). Both conjugates were purified from rat liver microsomes and analyzed by mass spectrometry, NMR, and UV experiments. On the basis of these results, M1 was identified as 5-O-β-glucopyranuronosyl-flavopiridol and M2 as 7-O-β-glucopyranuronosyl-flavopiridol. In conclusion, our results elucidate the enzymatic pathways of FLAP in rat and human liver, which must be considered during cancer therapy of patients.
Footnotes
-
Send reprint requests to: Walter Jäger, Ph.D., Institute of Pharmaceutical Chemistry, University of Vienna, Althanstrasse 14, A-1090 Vienna, Austria. E-mail:walter.jaeger{at}univie.ac.at
-
This work was supported by grants from the Jubiläumsfonds der Österreichischen Nationalbank (7935) and the Austrian Science Foundation (P 8911-Med).
- Abbreviations used are::
- FLAP
- flavopiridol
- LC/MS
- liquid chromatography/mass spectrometry
- UGT
- UDP- glucuronosyltransferase
- UDPGA
- uridine 5′-diphosphoglucuronic acid
- HPLC
- high-performance liquid chromatography
- DQF-COSY
- double quantum-filtered correlation spectroscopy
- TOCSY
- total correlation spectroscopy
- ROESY
- rotation frame Overhauser experiment spectroscopy
- HSQC
- heteronuclear single quantum correlation
- HMBC
- heteronuclear multiple bond correlation
- DMSO
- dimethyl sulfoxide
- 1D and 2D
- one- and two-dimensional
- Received October 24, 2000.
- Accepted January 4, 2001.
- The American Society for Pharmacology and Experimental Therapeutics
DMD articles become freely available 12 months after publication, and remain freely available for 5 years.Non-open access articles that fall outside this five year window are available only to institutional subscribers and current ASPET members, or through the article purchase feature at the bottom of the page.
|